OR18-05 Interleukin 21 Drives The Development Of Autoimmune Diabetes Mellitus During Immune Checkpoint Inhibitor Cancer Therapy

Disclosure: J.G. Ortega: None. L.N. Scott: None. S. Wang: None. S. Zhang: None. H. Chen: None. N. Huang: None. M. Lechner: None. Autoimmune diabetes mellitus is a rare but life-threatening side effect of immune checkpoint inhibitor (ICI) cancer therapy. Checkpoint inhibitors increase immune activati...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia Ortega, Jessica Rachel, Scott, Lauren N, Wang, Sarah, Zhang, Shile, Chen, Ho-Chung, Huang, Nicole, Lechner, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556985/
http://dx.doi.org/10.1210/jendso/bvad114.897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556985/
http://dx.doi.org/10.1210/jendso/bvad114.897

Ejemplares similares